Skip to main content
TipRanks
Go Ultimate75% OFF

Tunde Otulana Insider Profile

4 Followers

Tunde Otulana, Director at Allergy Therapeutics, holds 50.00K shares in Allergy Therapeutics (Ticker: GB:AGY). Most recently, Tunde Otulana Bought 25,000 shares of Allergy Therapeutics on Mar 16, 2018 for an estimated value of 9.70K .

Tunde Otulana's Trading History

AGY
Allergy Therapeutics
Mar 16, 2018DirectorInformative Buy9.70K£725.00
GB:AGY
Insider Shares: 50.00K (0.84%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Mar 16, 2018Informative Buy$9.70K25,000$0.39-47.10%―
Oct 12, 2017Informative Buy$12.66K25,000$0.51-48.30%―

You May Also Like

Tunde Otulana insider profile FAQ

What is the percentage of profitable transactions made by Tunde Otulana?
The percentage of profitable transactions made by Tunde Otulana is 0%.
What is the average return per transaction made by Tunde Otulana?
The average return per transaction made by Tunde Otulana is -47.70%.
What stocks does Tunde Otulana hold?
Tunde Otulana holds: GB:AGY stocks.
What was Tunde Otulana’s latest transaction?
Tunde Otulana’s latest transaction was an Informative Buy of 9.70K .
What was Tunde Otulana's most profitable transaction?
Tunde Otulana’s most profitable transaction was an Informative Buy of GB:AGY stock on March 16, 2018. The return on the trade was -47.10%.
What is Tunde Otulana's role in Allergy Therapeutics?
Tunde Otulana's role in Allergy Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.